January 30, 2012

The FDA announced the approval of Genentech's Erivedge (vismodegib) for adults with basal cell carcinoma who are not surgery or radiation therapy candidates and whose disease is locally advanced or has spread to other parts of the body.

September 8, 2010

The Food and Drug Administration has approved a generic drug for treating skin diseases made...

March 7, 2010

The Food and Drug Administration has approved Taro Pharmaceutical Industries’ generic version of a drug...

February 25, 2010

The Food and Drug Administration has given E. Fougera & Co. approval for the first...

January 5, 2010

A new study found that a nonsteroidal anti-inflammatory drug may reduce a patient's risk of...